Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2010
12/23/2010WO2010147975A1 Gamma secretase modulators
12/23/2010WO2010147226A1 Pyrazinooxazepine derivatives
12/23/2010WO2010147068A1 Substituted polycyclic carbamoylpyridone derivative
12/23/2010WO2010146025A1 Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
12/23/2010WO2010054278A3 Compounds for the treatment of inflammatory disorders
12/23/2010WO2010010435A3 Fused oxazole and thiazole derivatives as trpms modulators
12/23/2010US20100324054 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/23/2010US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/23/2010US20100324023 Imidazobenzazepine cgrp receptor antagonists
12/23/2010US20100323963 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
12/23/2010US20100323420 Regulated apoptosis
12/23/2010CA2765239A1 Pyrazinooxazepine derivatives
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2262364A2 Oxadiazoanthracene compounds for the treatment of diabetes
12/22/2010EP2089020B1 Macrocyclic peptides as hepatitis c virus inhibitors
12/22/2010EP2086980B1 Macrocyclic peptides as hepatitis c virus inhibitors
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN101925606A Compounds comprising a cyclobutoxy group
12/22/2010CN101925605A Tricyclic triazolic compounds
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101072779B 2,4 (4,6) pyrimidine derivatives
12/21/2010CA2528114C Monoclonal antibodies specific for buprenorphine and metabolites thereof
12/21/2010CA2450274C Benzoxazepine derivatives and their use as ampa receptor stimulators
12/16/2010WO2010144680A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010WO2010144679A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010WO2010142027A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010WO2010102778A3 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
12/16/2010US20100317832 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
12/16/2010US20100317657 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
12/16/2010US20100317651 Pyrazinooxazepine derivatives
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317645 Substituted diazepine sulfonamides as bombesin receptor subtype-1 modulators
12/16/2010US20100317623 HCV NS3 Protease Inhibitors
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010CA2774883A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2764567A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP2260043A1 Substituted sulfonamide derivatives
12/15/2010CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2010CN101235131B Method for preparing benzoxazine intermediate containing propargyl ether and resin thereof
12/14/2010US7851620 Methods for preparing diazonamides
12/14/2010US7851432 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents
12/14/2010CA2515343C Antiparasitic terpene alkaloids
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2355939C Antihistaminic spiro compounds
12/14/2010CA2326764C Acylbenzoxazines for enhancing synaptic response(s)
12/09/2010WO2010084499A9 Bicyclic heterocyclic spiro compounds
12/09/2010US20100312328 Drug-delivery endovascular stent and method of forming the same
12/09/2010US20100311966 Imidazole carbonyl compound
12/09/2010US20100311757 Salarins And Tulearins, Compositions And Uses Thereof
12/09/2010US20100311737 Pyrimido [4,5-b] -oxazines for use as dgat inhibitors
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor
12/09/2010US20100311713 Novel Azetidine Compounds Useful in the Treatment of Functional Gastrointestinal Disorders, Ibs and Functional Dyspepsia
12/09/2010US20100311593 Haloalkylmethyleneoxyphenyl-substituted ketoenols
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258704A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258415A2 Medical devices containing rapamycin analogs
12/08/2010EP2257557A2 Forms of rifaximin and uses thereof
12/08/2010EP2257551A2 Azatricyclic antibiotic compounds
12/08/2010EP2257542A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
12/08/2010CN1950380B (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
12/08/2010CN1759118B Diazepinoindole derivatives as kinase inhibitors
12/08/2010CN101910183A Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one
12/08/2010CN101910178A Gamma secretase modulators
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910121A Bis-(sulfonylamino) derivatives in therapy 066
12/08/2010CN101220035B A kind of alkaloid, method for preparing the same and application in antineoplastic or antimicrobial aspects
12/08/2010CN101031572B (R/S) rifamycin derivatives, their preparation and pharmaceutical compositions
12/07/2010US7846962 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/07/2010US7846949 liver X receptors (LXR) modulators such as Tert-butyl 2-(2,4,6-trifluoro-N-(3-hydroxyphenyl benzamido)acetate, useful in the treatment of LXR-associated diseases such as cardiovascular disorders, inflammation and disorders of glucose metabolism such as insulin resistance and obesity
12/07/2010US7846943 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010US20100305151 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305110 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100303928 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2255836A2 Medical devices containing rapamycin analogs
12/01/2010EP2254893A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents
12/01/2010EP2254892A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
12/01/2010CN101903395A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903392A Inhibitors of serine proteases
12/01/2010CN101903379A Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas
12/01/2010CN101903377A 6H-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
12/01/2010CN101903372A Heteroaryl derivatives as orexin receptor antagonists
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101899057A Preparation method of pyrimido-oxazole derivative and use thereof in medicine
11/2010
11/30/2010US7842814 deprotecting, aldol condensations, cleaving double bonds, deesterifying, alcoholization, oxidation with organometallic, lactonization
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010US20100298559 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst
11/25/2010US20100298557 Pyrazolopyrimidine compound
11/25/2010US20100298378 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 220